Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NATROX Wound Care is a medical technology company headquartered in Cambridge, UK, that specializes in advanced oxygen-based wound healing solutions. The company's flagship product, NATROX O2, is a portable, battery-powered device that delivers continuous topical oxygen therapy (cTOT) directly to the wound bed. This non-invasive treatment is designed to stimulate healing in chronic, hard-to-heal wounds such as diabetic foot ulcers and venous leg ulcers by promoting angiogenesis and collagen synthesis. The device is lightweight and silent, allowing patients to receive therapy 24/7 while maintaining their daily activities. Backed by extensive clinical evidence, NATROX Wound Care aims to reduce the global burden of chronic wounds and improve patient quality of life. The company operates globally with a strong presence in the UK, Europe, and the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NATROX.